Lamounier-Zepter Valéria, Ehrhart-Bornstein Monika, Bornstein Stefan R
Department of Endocrinology, Diabetes and Metabolism, University Medical Center, University of Dresden, 01307 Dresden, Germany.
Best Pract Res Clin Endocrinol Metab. 2006 Sep;20(3):355-67. doi: 10.1016/j.beem.2006.07.002.
Insulin resistance is not simply a problem of decreased glucose uptake in response to insulin, but a multifaceted syndrome that significantly increases the risk for cardiovascular disease. Insulin resistance is strongly associated with arterial hypertension and a pathogenetic role in the development of arterial hypertension has been suggested. One question that remains open concerns the clinical approach to insulin-resistant patients. Observational and clinical trial data suggest that lifestyle changes including weight reduction and regular physical activity can improve insulin sensitivity and reduce the incidence and mortality of cardiovascular disease. Daily physical activity of moderate intensity for 30 min has a cardioprotective effect and reduces insulin resistance, independent of the effect on body weight. A pharmacological therapy for insulin resistance reducing cardiovascular disease remains to be defined. Concerning the antihypertensive therapy of insulin-resistant hypertensive patients, most hypertensive guidelines fail to provide specific advice.
胰岛素抵抗并非仅仅是对胰岛素作出反应时葡萄糖摄取减少的问题,而是一种多方面的综合征,它会显著增加心血管疾病的风险。胰岛素抵抗与动脉高血压密切相关,并且有人提出其在动脉高血压的发展中具有致病作用。一个尚未解决的问题涉及对胰岛素抵抗患者的临床治疗方法。观察性和临床试验数据表明,包括减重和规律体育活动在内的生活方式改变可以改善胰岛素敏感性,并降低心血管疾病的发病率和死亡率。每天进行30分钟中等强度的体育活动具有心脏保护作用,并能降低胰岛素抵抗,这与对体重的影响无关。一种降低心血管疾病的胰岛素抵抗药物治疗方法仍有待确定。关于胰岛素抵抗型高血压患者的抗高血压治疗,大多数高血压指南未能提供具体建议。